𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk

✍ Scribed by Lee, S A; Ross, R K; Pike, M C

Book ID
109998530
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
129 KB
Volume
92
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast-cancer risk following long-term o
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy
✍ Cecilia Magnusson; John A. Baron; Nestor Correia; Reinhold Bergström; Hans-Olov 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 62 KB 👁 2 views

While use of hormone-replacement therapy (HRT) effectively alleviates menopausal symptoms and prevents osteoporosis and possibly cardiovascular disease, there is concern of a detrimental impact on breast-cancer risk. There is a particular lack of data regarding the effect of long-term use of oestrog

Risk of different histological types of
Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy
✍ Dieter Flesch-Janys; Tracy Slanger; Elke Mutschelknauss; Silke Kropp; Nadia Obi; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 382 KB 👁 1 views

## Abstract In a large population‐based case–control study in Germany, including 3,464 breast cancer cases aged 50–74 at diagnosis and 6,657 population based and frequency matched controls, we investigated the effects of menopausal hormone therapy (HT) by type, regimen, timing and progestagenic con

Menopausal hormone therapy and breast ca
Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European Prospective Investigation into Cancer and Nutrition
✍ Kjersti Bakken; Agnès Fournier; Eiliv Lund; Marit Waaseth; Vanessa Dumeaux; Fran 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 179 KB 👁 2 views

## Abstract Menopausal hormone therapy (MHT) is characterized by use of different constituents, regimens and routes of administration. We investigated the association between the use of different types of MHT and breast cancer risk in the EPIC cohort study. The analysis is based on data from 133,74